Recombinant Macaca fascicularis 60S ribosomal protein L26 (RPL26)

What is Macaca fascicularis RPL26 and what are its basic functions?

RPL26 is a component of the 60S ribosomal subunit that plays crucial roles in ribosome assembly and protein synthesis. In Macaca fascicularis (cynomolgus monkey), as in other species, RPL26 belongs to the L24P family of ribosomal proteins and is primarily located in the cytoplasm. Ribosomes, the cellular organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit, with these subunits together composed of 4 RNA species and approximately 80 structurally distinct proteins .

Beyond its canonical role in the ribosome, RPL26 has notable extraribosomal functions, particularly in stress response pathways. Based on comparative studies with human RPL26, Macaca fascicularis RPL26 likely enhances p53 translation following DNA damage through interaction with specific mRNA structures. This regulatory function represents an important mechanism for cellular stress response that appears to be conserved across primate species .

What are standard methods for recombinant production of Macaca fascicularis RPL26?

Based on established protocols for human RPL26 production, recombinant Macaca fascicularis RPL26 can be effectively expressed in E. coli expression systems. The typical procedure includes:

• Gene synthesis or cloning of the Macaca fascicularis RPL26 coding sequence into an appropriate expression vector

• Transformation into E. coli expression hosts

• Induction of protein expression under optimized conditions

• Cell lysis and protein purification through affinity chromatography

• Quality control using SDS-PAGE (aiming for >85% purity as achieved with human RPL26)

For proper reconstitution and storage of the purified protein:

• Briefly centrifuge the vial before opening to collect contents

• Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL

• Add glycerol to a final concentration of 5-50% for long-term storage

• Store at -20°C or -80°C in aliquots to avoid repeated freeze-thaw cycles

• Working aliquots can be stored at 4°C for up to one week

These protocols should yield functional recombinant Macaca fascicularis RPL26 suitable for various research applications, though specific optimization may be required based on sequence differences from human RPL26.

How does RPL26 participate in p53 translation regulation in primates like Macaca fascicularis?

RPL26 plays a sophisticated role in regulating p53 translation, particularly following cellular stress such as DNA damage. In primate cells, including those from Macaca fascicularis, this regulatory mechanism likely follows the pattern observed in human cells:

• RPL26 binds to a double-stranded RNA structure formed by complementary sequences in the 5′- and 3′-UTRs of p53 mRNA

• This binding enhances p53 translation after DNA damage

• The RPL26-mediated translational enhancement requires intact base pairing within the p53 UTR interaction regions

A key molecular interaction in this regulatory system involves nucleolin (NCL), which functions as a repressor of p53 translation under normal conditions. After cellular stress:

• RPL26 interacts with nucleolin at its RNA-binding domain

• This interaction disrupts nucleolin homodimers that normally stabilize the double-stranded RNA structure in p53 mRNA

• The disruption of nucleolin homodimers acts as a molecular switch from translational repression to activation

This intricate interplay between RPL26, nucleolin, and p53 mRNA represents a crucial mechanism for post-transcriptional regulation of p53 following cellular stress, allowing rapid protein induction without requiring new mRNA synthesis. The high genomic similarity between Macaca fascicularis and humans suggests this regulatory system is conserved across these primate species .

What is the significance of RPL26 UFMylation in protein quality control?

RPL26 undergoes a critical post-translational modification called UFMylation that links it to an essential protein quality control pathway. Recent research has revealed that:

• UFMylation (attachment of UFM1, a ubiquitin-like modifier) occurs at two conserved lysine residues near the COOH-terminus of RPL26

• This modification is specifically induced when ribosomes stall during protein translocation into the endoplasmic reticulum (ER)

• RPL26 UFMylation enables the degradation of stalled nascent chains

What makes this quality control mechanism particularly significant is its distinct degradation pathway:

• Unlike ERAD (ER-associated degradation) or cytosolic RQC (ribosome-associated quality control) that use proteasomes

• UFMylated-ribosome-associated quality control targets translocation-arrested ER proteins to lysosomes for degradation

This UFMylation-dependent quality control mechanism is upregulated during erythroid differentiation to manage increased secretory flow. Compromising this system impairs protein secretion and ultimately hemoglobin production, leading to anemia in mice and potentially contributing to abnormal neuronal development in humans .

Given the conservation of UFMylation machinery across metazoans, this quality control pathway is likely functionally significant in Macaca fascicularis as well, particularly in tissues with high secretory demands.

What experimental approaches are optimal for investigating RPL26-nucleolin interactions?

To thoroughly investigate the interactions between RPL26 and nucleolin in Macaca fascicularis, researchers should employ a multi-technique approach:

Protein-Protein Interaction Studies:

• Co-immunoprecipitation (Co-IP) to detect native complexes of RPL26 and nucleolin

• GST pull-down assays using recombinant proteins to validate direct interactions

• Proximity ligation assays (PLA) to visualize interactions in situ

• FRET or BiFC to monitor interactions in live cells

Protein-RNA Interaction Analysis:

• RNA immunoprecipitation to identify RNA targets of both proteins

• Electrophoretic mobility shift assays (EMSA) to assess binding to the p53 mRNA 5′-3′-UTR interaction region

• RNA footprinting to determine precise binding sites

• RNA structural analysis using chemical probing to examine how these proteins affect RNA conformation

Functional Studies:

• Translational reporter assays using constructs with p53 5′ and 3′ UTRs surrounding luciferase coding sequence

• Mutagenesis of the RNA-binding domain of nucleolin to assess its requirement for RPL26 interaction

• Point mutations in the nucleolin-interacting region of RPL26 to evaluate effects on binding and function

Comparing Structural Impact:

• Analysis of how RPL26 disrupts nucleolin dimers using techniques like analytical ultracentrifugation

• Mapping of interaction domains through deletion constructs and domain swapping experiments

This comprehensive experimental toolkit would enable researchers to characterize the molecular mechanisms underlying RPL26-nucleolin interactions in Macaca fascicularis and their role in regulating p53 translation.

How can Macaca fascicularis RPL26 be used in comparative studies with human RPL26?

Macaca fascicularis RPL26 provides an excellent opportunity for comparative studies with human RPL26 due to the high genomic similarity between these species (92.83%) . Such comparative studies can yield insights in several key areas:

Evolutionary Conservation Analysis:

Functional Comparative Studies:

• Compare binding affinity of human and Macaca fascicularis RPL26 to identical RNA targets

• Assess interchangeability in functional assays (can one substitute for the other?)

• Investigate species-specific differences in post-translational modifications, particularly UFMylation

• Determine whether the mechanisms of stress-induced p53 translation enhancement are identical

Translational Research Applications:

• Validate Macaca fascicularis as a model for studying RPL26-related human diseases

• Determine whether species-specific differences impact drug responses or disease mechanisms

• Develop cross-reactive tools and reagents that work across primate species

• Evaluate conservation of quality control mechanisms like UFMylation-dependent regulation

Such comparative studies provide crucial context for interpreting results from Macaca fascicularis models and their relevance to human biology and disease.

What are the challenges in studying UFMylation of RPL26 in Macaca fascicularis?

Investigating UFMylation of RPL26 in Macaca fascicularis presents several technical and biological challenges:

Technical Challenges:

• Detection Sensitivity: UFMylation may occur at low stoichiometry or transiently during specific cellular conditions, requiring highly sensitive detection methods

• Antibody Specificity: Developing antibodies that specifically recognize UFMylated RPL26 without cross-reactivity to unmodified protein

• Site Identification: Precisely mapping UFMylation sites requires mass spectrometry approaches that can distinguish this modification from other lysine modifications

Biological Challenges:

• Stimulus Specificity: Determining the exact cellular conditions that trigger RPL26 UFMylation in Macaca fascicularis cells

• Cell Type Variability: UFMylation levels may vary across different tissues, with heightened activity in cells with high secretory flow such as erythroid precursors

• Temporal Dynamics: Capturing the dynamic nature of modification and demodification during quality control processes

Methodological Approach Table:

Overcoming these challenges requires specialized techniques and careful experimental design, but would significantly advance our understanding of this critical quality control pathway in primate systems.

How can recombinant Macaca fascicularis RPL26 be used to study p53 regulation mechanisms?

Recombinant Macaca fascicularis RPL26 provides a powerful tool to dissect the molecular mechanisms of p53 regulation, especially when used in the following methodological approaches:

In vitro Translation Systems:

• Add purified recombinant RPL26 to cell-free translation systems programmed with p53 mRNA

• Quantify changes in translation efficiency with varying concentrations of RPL26

• Compare wild-type RPL26 with mutated versions to identify functional domains

• Assess competition or cooperation with other regulatory factors like nucleolin

RNA Binding Studies:

• Use electrophoretic mobility shift assays (EMSAs) to characterize binding to p53 mRNA structures

• Perform RNA footprinting to map the precise binding sites on p53 mRNA

• Compare binding affinity to wild-type versus mutated p53 mRNA structures

• Investigate how RPL26 and nucleolin compete for binding to the same RNA regions

Reconstitution Experiments:

• Deplete endogenous RPL26 using RNAi or CRISPR approaches

• Rescue with recombinant Macaca fascicularis RPL26

• Assess restoration of p53 induction after DNA damage

• Compare rescue efficiency with human RPL26 to identify species-specific differences

Structure-Function Analysis:

• Generate domain deletion and point mutation variants of recombinant RPL26

• Test each variant's ability to enhance p53 translation

• Map regions required for interaction with nucleolin

• Identify domains involved in RNA binding versus protein-protein interactions

These approaches can reveal the precise mechanisms by which RPL26 regulates p53 translation, particularly following cellular stress, and how this regulation is coordinated with other factors like nucleolin.

How does sequence variation between Macaca fascicularis and human RPL26 affect experimental design?

When designing experiments that involve both Macaca fascicularis and human RPL26, researchers must carefully consider potential sequence variations and their experimental implications:

• Antibody recognition: Antibodies raised against human RPL26 may have variable cross-reactivity with Macaca fascicularis RPL26

• Protein-protein interactions: Subtle amino acid differences might alter interaction affinities

• Post-translational modification sites: Key regulatory sites might be conserved or varied

Experimental Design Adjustments:

Cross-Species Validation Strategy:

• Start with functional assays using recombinant proteins from both species

• Identify any differences in activity or binding properties

• Map these differences to specific sequence variations

• Use this information to design chimeric proteins that isolate functional domains

• Validate findings in cellular contexts from both species

This approach ensures that experimental results can be properly interpreted in the context of species-specific differences, strengthening the translational value of research conducted using Macaca fascicularis models.

How can Macaca fascicularis RPL26 research contribute to understanding human disease mechanisms?

Research on Macaca fascicularis RPL26 offers significant potential for understanding human disease mechanisms, particularly in conditions involving disrupted protein synthesis, quality control, and stress response pathways:

Cancer Biology Applications:
The role of RPL26 in regulating p53 translation after DNA damage positions it as a potential modulator of cancer development and progression. Macaca fascicularis models can help elucidate:

• How alterations in RPL26-mediated p53 regulation contribute to tumor development

• Whether targeting the RPL26-nucleolin interaction could enhance p53 activity in tumors

• The impact of RPL26 dysregulation on cellular responses to DNA-damaging cancer therapies

Hematological Disorders:
RPL26 UFMylation has been shown to be critical during erythroid differentiation, with implications for:

• Understanding the molecular basis of certain anemias

• Investigating how defects in protein quality control contribute to ineffective erythropoiesis

• Developing targeted interventions for disorders of red blood cell production

Neurodevelopmental Disorders:
The UFMylation pathway has been linked to abnormal neuronal development in humans:

• Macaca fascicularis models can help identify how RPL26 UFMylation affects neuron-specific protein synthesis

• Studies can examine the impact on secretory protein production in neurons

• Research can determine whether RPL26 dysregulation contributes to specific neurodevelopmental conditions

Comparative Disease Modeling Table:

The close evolutionary relationship between Macaca fascicularis and humans makes these models particularly valuable for translational research on RPL26-related disease mechanisms .

What are the most significant recent advances in understanding Macaca fascicularis RPL26 biology?

The most significant recent advances in understanding Macaca fascicularis RPL26 biology come from integrating findings across comparative genomics, protein function studies, and quality control mechanisms:

• Comparative Genomic Insights: Whole-genome sequencing of Macaca fascicularis has revealed high genomic similarity with humans (92.83% sequence identity), providing a strong foundation for comparative studies of RPL26 function and evolution . This genomic analysis enables more precise understanding of RPL26 conservation across primate species.

• Regulatory Mechanisms in p53 Translation: Research has uncovered the sophisticated interplay between RPL26 and nucleolin in regulating p53 translation, particularly following cellular stress. The identification of specific mechanisms by which RPL26 enhances p53 translation by disrupting nucleolin's repressive function provides insight into extraribosomal functions of RPL26 that are likely conserved in Macaca fascicularis .

• Quality Control Pathway Discovery: The discovery of RPL26 UFMylation as a critical component of a translocation-associated quality control system represents a major advance. This modification occurs at conserved lysine residues and enables the lysosomal degradation of stalled nascent chains during protein translocation into the ER . The significance of this pathway during erythroid differentiation and neuronal development highlights its importance in tissues with high secretory demands.

• Macaca fascicularis as a Translational Model: The characterization of Macaca fascicularis at the genomic level, including the identification of 17,387 orthologs of human protein-coding genes, enhances the value of this species as a model for studying human disease mechanisms . This genomic foundation strengthens the translational relevance of findings related to RPL26 function in this primate model.

These advances collectively deepen our understanding of RPL26 biology beyond its canonical ribosomal function, revealing its integral roles in cellular stress responses and protein quality control that are likely well-conserved between Macaca fascicularis and humans.

What are the key unsolved questions about Macaca fascicularis RPL26 that warrant further investigation?

Despite significant progress in understanding RPL26 biology, several key questions specific to Macaca fascicularis RPL26 remain unanswered and merit focused investigation:

1. Species-Specific Functional Differences:

• Are there any functional differences between Macaca fascicularis and human RPL26, particularly in stress response pathways?

• Do subtle sequence variations affect interaction affinities with partners like nucleolin?

• Could species-specific differences in RPL26 function contribute to phenotypic variations between these primates?

2. Tissue-Specific Expression and Regulation:

• How does RPL26 expression and UFMylation vary across different tissues in Macaca fascicularis?

• Are there tissue-specific regulatory mechanisms controlling RPL26 function?

• Do certain tissues exhibit unique RPL26-dependent quality control requirements?

3. Developmental Timing and Regulation:

• How does RPL26 function change during Macaca fascicularis development?

• Is RPL26 UFMylation differentially regulated during specific developmental windows?

• What role does RPL26 play in developmental processes with high protein synthesis demands?

4. Integration with Other Quality Control Systems:

• How does RPL26 UFMylation coordinate with other protein quality control pathways in Macaca fascicularis?

• Are there species-specific differences in how these quality control systems interact?

• Could these differences impact the response to cellular stresses or protein misfolding diseases?

5. Therapeutic Potential and Translational Applications:

• Could modulating RPL26 function or its UFMylation provide therapeutic benefits in disease models?

• How predictive are Macaca fascicularis RPL26 studies for human responses to similar interventions?

• What are the consequences of RPL26 dysfunction in diseases that could be modeled in Macaca fascicularis?